End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,568 ARS | -1.15% |
|
-5.90% | +34.65% |
06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
06-14 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
- Stock Market
- Equities
- AMGN Stock
- AMGN Stock
- News Amgen Inc.
- Analyst Reco.